BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12837987)

  • 1. Abnormal fragile histidine triad expression in advanced cervical cancer and evaluation of its utility as a prognostic factor.
    Machida S; Ohwada M; Saga Y; Suzuki M
    Oncology; 2003; 65(1):89-93. PubMed ID: 12837987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factor.
    Krivak TC; McBroom JW; Seidman J; Venzon D; Crothers B; MacKoul PJ; Rose GS; Carlson JW; Birrer MJ
    Cancer Res; 2001 Jun; 61(11):4382-5. PubMed ID: 11389064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma.
    Baykal C; Ayhan A; Al A; YĆ¼ce K; Ayhan A
    Int J Gynecol Cancer; 2003; 13(2):192-6. PubMed ID: 12657123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer.
    Takizawa S; Nakagawa S; Nakagawa K; Yasugi T; Fujii T; Kugu K; Yano T; Yoshikawa H; Taketani Y
    Br J Cancer; 2003 Apr; 88(8):1213-6. PubMed ID: 12698186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction between abnormal expression of fragile histidine triad and methyl-CpG-binding protein 2 on cervical cancerization].
    Yang Q; Li Y; Wang L; Song ZC; Feng MJ; Ding L; Wang JT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):689-693. PubMed ID: 29860820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
    Shi HR; Wu QH; Suo ZH; Nesland JM
    Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness.
    Yoon SO
    Hum Pathol; 2007 Feb; 38(2):326-31. PubMed ID: 17137614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
    Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
    Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
    Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
    Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
    Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
    Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis.
    Huang LW; Chao SL; Chen TJ
    Gynecol Oncol; 2003 Aug; 90(2):331-7. PubMed ID: 12893195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
    Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
    Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of fragile histidine triad expression in colorectal carcinoma.
    Zhao P; Lu Y; Hu Y; Zhong M; Li Z; Li X
    Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):124-7. PubMed ID: 12419158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction between folate deficiency and aberrant expression related to fragile histidine triad gene in the progression of cervical cancerization].
    Chen X; Wang J; Bai L; Ding L; Wu T; Bai L; Xu J; Sun X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Apr; 36(4):387-92. PubMed ID: 25975556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between expression of Fhit and biological behaviors of hypopharyngeal carcinoma].
    Wu H; Luan X; Zhou W; Pan X; Xu F; Lei D
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):249-50. PubMed ID: 16739375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma.
    Lee EJ; Lee BB; Kim JW; Shim YM; Hoseok I; Han J; Cho EY; Park J; Kim DH
    Eur J Cancer; 2006 May; 42(7):972-80. PubMed ID: 16564166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer.
    Toledo G; Sola JJ; Lozano MD; Soria E; Pardo J
    Mod Pathol; 2004 Apr; 17(4):440-8. PubMed ID: 14976524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
    Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
    Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.